Healthcare Strides Shasun experienced the toughest year. Will the woes come to an end? Updated : June 26, 2018 03:16 PM IST In November 2017, Strides Shasun announced its decision to sell its branded generic business in India to Eris Life for Rs 500 crore. The institutional business as of FY17 was around 16 percent of the company’s sales. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.